This video is the first of two that explains how to mud and tape a room once the sheetrock is hung. **Tools needed:** - ...
PALM BAY, Fla. — Crews from Palm Bay Fire Rescue contained brush fires covering about 5 acres Wednesday in the area of an unfinished development locally known as the Compound. A week prior, ...
PHILADELPHIA, PA, UNITED STATES, January 13, 2026 /EINPresswire.com/ -- Aquelyst develops environmental and molecular ...
A group of compounding pharmacies has filed a lawsuit against the FDA, challenging the agency’s decision to remove semaglutide — which is used to treat Type 2 diabetes and obesity — from the drug ...
Note: Compounded drugs are not approved by the U.S. Food and Drug Administration (FDA) and may carry greater risks than FDA-approved treatments. Despite new rules limiting their manufacture, ...
On Sunday night, I showed Parker her latest dividend reinvestment. Another quarter. Another automatic purchase. Another step forward. She glanced at the screen, nodded, and said, “Mmmhmm.” That was it ...
WASHINGTON, Jan 15 (Reuters) - Drugmakers Eli Lilly (LLY.N), opens new tab and Novo Nordisk (NOVOb.CO), opens new tab have been sued in Texas by a compounding pharmacy that alleges they are illegally ...
Strive Compounding Pharmacy filed a federal antitrust lawsuit Jan. 14 against Eli Lilly and Novo Nordisk, alleging the two drugmakers used their market power to restrict access to compounded GLP-1 ...
Strive Compounding Pharmacy alleged in its lawsuit that Eli Lilly and Novo Nordisk have worked to lock telehealth providers in exclusive partnerships, disallowing them from offering compounded ...
Arizona-based Strive Compounding Pharmacy has sued Eli Lilly (LLY) and Novo Nordisk (NVO) in a Texas federal court alleging that the drug giants coordinated to stifle competition by hindering access ...
GILBERT, Ariz., Jan. 14, 2026 /PRNewswire/ -- Strive Compounding Pharmacy, one of the nation's most celebrated providers of compounded medications, has filed a federal antitrust lawsuit against ...
Jan 12 (Reuters) - Novo Nordisk ‌CEO Mike Doustdar said on Monday as ‌many as 1.5 million patients in the U.S. may be using compounded versions of blockbuster GLP-1 drugs, underscoring how cheaper, ...